GORASP1 and prostate carcinoma: Giantin deficiency in androgen-independent prostate cancer cells leads to Golgi targeting glycosyltransferases and α-mannosidase IA transferring from Giantin to GM130-GRASP65, and the disorder of glycosylation environment at this site would cause the complete change of downstream glycosylation pathway (80).